[Ulceration of lymphomatous skin lesions in a patient with Sezary syndrome treated with brentuximab-vedotin].
Sign Up to like & getrecommendations! Published in 2020 at "Annales de dermatologie et de venereologie"
DOI: 10.1016/j.annder.2019.09.615
Abstract: BACKGROUND Brentuximab-vedotin (BV), an anti-CD30 agent combined with an anti-neoplastic agent, has recently yielded promising results in the treatment of cutaneous T-lymphomas such as Sezary syndrome. Surprisingly, these results are observed regardless of levels of CD30 expression… read more here.
Keywords: brentuximab vedotin; skin lesions; sezary syndrome; ulceration ... See more keywords
TOX Expression in Mycosis Fungoides and Sezary Syndrome
Sign Up to like & getrecommendations! Published in 2022 at "Diagnostics"
DOI: 10.3390/diagnostics12071582
Abstract: Mycosis fungoides (MF) and Sezary syndrome (SS) are the two most common type of cutaneous T-cell lymphoma (CTCL). Currently, no markers can be clearly related to prognosis or to differential diagnosis between early stages and… read more here.
Keywords: sezary syndrome; marker; mycosis fungoides; tox expression ... See more keywords